News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PERRY MATTHEW D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 10,967 options to buy
@ $21.39, valued at
$234.6k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 200,000 shares
@ $25, valued at
$5M
|
|
| 05/27/2020 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 6,152 options to buy
@ $21.27, valued at
$130.9k
|
|
| 05/20/2019 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 120,000 options to buy
@ $0.8411, valued at
$100.9k
|
|
| 05/20/2019 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 8,167 options to buy
@ $15.59, valued at
$127.3k
|
|
| 05/21/2018 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 5,052 options to buy
@ $25.16, valued at
$127.1k
|
|
| 05/21/2018 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 60,000 options to buy
@ $4.61, valued at
$276.6k
|
|
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 01/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2016 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 347,360 options to buy
@ $0 |
|
| 01/13/2016 |
4
| PERRY MATTHEW D (Director) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 84,034 options to buy
@ $0 |
|
| 01/21/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |
|
|